Kelli K. Gant

Kelli K. Gant sold 20,000 shares of HCC at $110.00 on 2026-06-02 via scheduled 10b5-1 plan; stock up 25.4% in 30 days.

Kelli K. Gant executed a scheduled sale of 20,000 shares at $110.00 on 2026-06-02 under a pre-arranged 10b5-1 trading plan adopted on 2026-02-26, reducing her HCC holdings from 87,775 shares to 67,775 shares. The stock has appreciated 25.4% over the prior 30 days and 40.4% over 90 days, trading near its 52-week high of $110.39. Her prior sale at HCC (2024-07-03) saw the stock decline 17.3% in the 30 days and 15.9% in the 90 days following that trade. Because this transaction is scheduled under a 10b5-1 plan rather than discretionary, it reflects a pre-commitment made weeks in advance rather than a real-time market decision.

CAO Gant sold 10,000 HCC shares at $75.06, retaining 61,678 shares; stock now trades at $70.21

Chief Administrative Officer Kelli K. Gant sold 10,000 shares (14.0% of pre-transaction holdings) at $75.06 on 2024-07-03, generating $750,600.00. At the current price of $70.21, the executive's remaining position of 61,678 shares represents a stake in a company with $3.7B market cap and strong recent fundamentals: $137.0M net income on $503.5M quarterly revenue, despite annual revenue declining 3.6% year-over-year. The stock has recovered 17.1% over 90 days and now trades 4.3% below its 52-week high of $73.37, placing it near cyclical strength. The sale occurred near the peak of the 52-week range, above current trading levels, but without visibility into whether this represents a discrete rebalancing event or part of a broader pattern.